Natco Seeks Emergency Approval of Oral Treatment For Coronavirus…Stock gains 5%
Natco Pharma has applied to India’s Central Drugs Standard Control Organization for approval of Phase-III clinical trial of Molnupiravir capsules for the treatment of Covid-19 patients.